Matrix M with R78C and/or RH5.1 clinical trials

A Phase Ia Clinical Trial to Assess the Safety and Immunogenicity of the Blood-stage Malaria Candidate Vaccines RH5.1 in Matrix-M and R78C in Matrix-M in Healthy UK Adults

This study is testing new shots for malaria in healthy adults in the UK. Researchers want to see if the shots are safe, help the body fight malaria, and possibly prevent malaria infection. It's an early-stage study to gather important information.